46.70
price up icon6.11%   2.69
after-market Dopo l'orario di chiusura: 46.70
loading
Precedente Chiudi:
$44.01
Aprire:
$43.83
Volume 24 ore:
1.23M
Relative Volume:
1.28
Capitalizzazione di mercato:
$3.69B
Reddito:
$399.58M
Utile/perdita netta:
$-54.04M
Rapporto P/E:
-62.27
EPS:
-0.75
Flusso di cassa netto:
$40.13M
1 W Prestazione:
+18.89%
1M Prestazione:
+27.14%
6M Prestazione:
+71.94%
1 anno Prestazione:
+17.96%
Intervallo 1D:
Value
$43.24
$46.93
Intervallo di 1 settimana:
Value
$37.98
$46.93
Portata 52W:
Value
$22.61
$47.32

Veracyte Inc Stock (VCYT) Company Profile

Name
Nome
Veracyte Inc
Name
Telefono
(650) 243-6300
Name
Indirizzo
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Name
Dipendente
824
Name
Cinguettio
@veracyte
Name
Prossima data di guadagno
2025-02-24
Name
Ultimi documenti SEC
Name
VCYT's Discussions on Twitter

Confronta VCYT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
VCYT
Veracyte Inc
46.70 3.48B 399.58M -54.04M 40.13M -0.75
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
586.07 220.72B 43.74B 6.58B 6.11B 17.31
Diagnostics & Research icon
DHR
Danaher Corp
226.98 160.62B 24.27B 3.50B 5.02B 4.8589
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
752.14 57.96B 4.17B 1.03B 940.22M 12.61
Diagnostics & Research icon
A
Agilent Technologies Inc
153.60 42.88B 6.79B 1.22B 1.09B 4.2644
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
228.18 38.30B 15.90B 1.28B 2.21B 7.2842

Veracyte Inc Stock (VCYT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-10-20 Iniziato Canaccord Genuity Hold
2025-03-20 Iniziato Craig Hallum Buy
2024-12-05 Downgrade Goldman Buy → Neutral
2024-11-15 Iniziato Wolfe Research Outperform
2024-10-16 Iniziato UBS Buy
2024-10-10 Iniziato Guggenheim Buy
2024-02-23 Reiterato Needham Buy
2023-01-18 Downgrade Raymond James Outperform → Mkt Perform
2023-01-05 Iniziato Scotiabank Sector Outperform
2022-01-07 Iniziato Stephens Overweight
2021-11-18 Ripresa Goldman Buy
2021-06-15 Iniziato Raymond James Outperform
2021-02-18 Ripresa Needham Buy
2021-01-28 Iniziato Truist Buy
2020-11-10 Iniziato KeyBanc Capital Markets Sector Weight
2020-09-09 Iniziato Morgan Stanley Underweight
2019-07-31 Iniziato Lake Street Buy
2019-07-02 Iniziato Needham Buy
2018-11-29 Downgrade Janney Buy → Neutral
2018-10-31 Aggiornamento Janney Neutral → Buy
2017-11-07 Downgrade Janney Buy → Neutral
2017-11-07 Downgrade Piper Jaffray Overweight → Neutral
2017-08-31 Ripresa BTIG Research Buy
2016-11-14 Ripresa Leerink Partners Outperform
2015-12-18 Iniziato Cantor Fitzgerald Buy
2015-06-11 Reiterato Leerink Partners Outperform
2013-11-26 Iniziato William Blair Outperform
Mostra tutto

Veracyte Inc Borsa (VCYT) Ultime notizie

pulisher
Nov 23, 2025

Veracyte Stock Soars Amid Strong Earnings and New Price Targets - timothysykes.com

Nov 23, 2025
pulisher
Nov 22, 2025

Veracyte Stock Surges Amid Investor Conferences and Robust Earnings - StocksToTrade

Nov 22, 2025
pulisher
Nov 22, 2025

Is Veracyte Inc a good long term investmentMoving Average Crossovers & AI-Based Insights for Consistent Profits - earlytimes.in

Nov 22, 2025
pulisher
Nov 22, 2025

Veracyte Stock Soars Amid Revenue and EPS Surprises - timothysykes.com

Nov 22, 2025
pulisher
Nov 22, 2025

Veracyte, Inc. (NASDAQ:VCYT) Stock Catapults 27% Though Its Price And Business Still Lag The Industry - simplywall.st

Nov 22, 2025
pulisher
Nov 21, 2025

Insider Sell: Jens Holstein Sells 10,000 Shares of Veracyte Inc (VCYT) - GuruFocus

Nov 21, 2025
pulisher
Nov 21, 2025

Veracyte Director Jens Holstein Sells 10,000 Shares - TradingView

Nov 21, 2025
pulisher
Nov 21, 2025

Dir Holstein Sells 10,000 ($423.6K) Of Veracyte Inc [VCYT] - TradingView

Nov 21, 2025
pulisher
Nov 21, 2025

[Form 4] VERACYTE, INC. Insider Trading Activity - Stock Titan

Nov 21, 2025
pulisher
Nov 21, 2025

Will Veracyte Inc. (12V) stock sustain bullish trend into 2025Earnings Overview Summary & Safe Entry Point Identification - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Can Veracyte Inc. (12V) stock surprise markets with earningsTrade Volume Summary & Fast Exit Strategy with Risk Control - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Veracyte at Stephens Conference: Strategic Growth and Expansion By Investing.com - Investing.com India

Nov 20, 2025
pulisher
Nov 20, 2025

Veracyte at Stephens Conference: Strategic Growth and Expansion - Investing.com

Nov 20, 2025
pulisher
Nov 20, 2025

Veracyte at Jefferies London: Strategic Expansion and Growth By Investing.com - Investing.com Nigeria

Nov 20, 2025
pulisher
Nov 20, 2025

Veracyte at Jefferies London: Strategic Expansion and Growth - Investing.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will Veracyte Inc. stock gain from government policiesShort Setup & Weekly High Conviction Trade Ideas - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will Veracyte Inc. (12V) stock profit from fiscal stimulus2025 Key Lessons & Capital Efficiency Focused Strategies - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Can Veracyte Inc. (12V) stock sustain breakout momentumRisk Management & Daily Entry Point Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How Veracyte Inc. stock performs in interest rate cyclesPortfolio Return Summary & Daily Profit Focused Screening - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How to read the order book for Veracyte Inc.July 2025 Catalysts & Risk Adjusted Buy/Sell Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Tools to assess Veracyte Inc.’s risk profileEarnings Beat & AI Enhanced Trading Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Veracyte Inc. (12V) stock cheap vs fundamentalsGap Down & Verified Momentum Stock Watchlist - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Heatmap analysis for Veracyte Inc. and competitorsMarket Trend Review & Step-by-Step Trade Execution Guides - newser.com

Nov 19, 2025

Veracyte Inc Azioni (VCYT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
diagnostics_research DGX
$190.58
price down icon 0.35%
diagnostics_research LH
$265.31
price down icon 0.12%
diagnostics_research WAT
$399.54
price up icon 1.41%
diagnostics_research MTD
$1,470.14
price up icon 1.22%
$238.58
price up icon 3.45%
diagnostics_research IQV
$228.18
price up icon 1.46%
Capitalizzazione:     |  Volume (24 ore):